Vistagen Therapeutics, Inc. SEC filings VTGN

Vistagen Therapeutics, Inc. has 908 filings in SEC EDGAR's recent list, going back to Sep 11, 2007. Its latest annual report, Form 10-K, was filed on Jun 15, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (exit or restructuring costs, other events). The company's fiscal year ends on March 31.

Vistagen Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Exit or restructuring costs, Other events
Oct 30, 2026 Oct 26, 2026
8-K Current report
Officer or director change
Oct 9, 2026 Oct 7, 2026
8-K Current report
Regulation FD disclosure
Sep 25, 2026 Sep 25, 2026
8-K Current report
Other events
Sep 24, 2026 Sep 24, 2026
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
8-K Current report
Shareholder vote results
Sep 11, 2026 Sep 10, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 6, 2026 Aug 6, 2026
8-K Current report
Listing notice
Aug 5, 2026 Aug 4, 2026
DEFA14A Additional proxy material Jul 31, 2026 —
DEF 14A Proxy statement Jul 31, 2026 Jul 31, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 31, 2026 Jul 29, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2026 Jun 30, 2026
8-K Current report
Officer or director change
Jun 17, 2026 Jun 16, 2026
10-K Annual report Jun 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
Jun 15, 2026 Jun 15, 2026
8-K Current report
Other events
Jun 9, 2026 Jun 9, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 19, 2026 May 18, 2026
8-K Current report
Other events
May 12, 2026 May 12, 2026
8-K Current report
Other events
May 8, 2026 May 8, 2026
8-K Current report
Other events
Apr 28, 2026 Apr 22, 2026
8-K Current report
Officer or director change
Apr 13, 2026 Apr 7, 2026
8-K Current report
Listing notice
Apr 2, 2026 Apr 1, 2026
8-K Current report
Officer or director change
Mar 18, 2026 Mar 17, 2026
8-K Current report
Regulation FD disclosure
Mar 16, 2026 Mar 16, 2026
8-K Current report
Other events
Mar 11, 2026 Mar 5, 2026
8-K Current report
Officer or director change
Feb 20, 2026 Feb 13, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
8-K Current report
Listing notice
Feb 6, 2026 Feb 3, 2026
8-K Current report
Regulation FD disclosure
Jan 9, 2026 Jan 9, 2026
8-K Current report
Other events
Dec 22, 2025 Dec 17, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 3, 2025 Nov 28, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Regulation FD disclosure
Nov 4, 2025 Nov 3, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 29, 2025 Oct 27, 2025
8-K Current report
Officer or director change, Shareholder vote results
Sep 15, 2025 Sep 9, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
DEFA14A Additional proxy material Jul 28, 2025 —
DEF 14A Proxy statement Jul 28, 2025 Sep 9, 2025
8-K Current report
Officer or director change
Jun 25, 2025 Jun 23, 2025
8-K Current report
Results of operations, Other events
Jun 17, 2025 Jun 17, 2025
424B5 Prospectus supplement Jun 17, 2025 —
10-K Annual report Jun 17, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Jun 2, 2025 Jun 2, 2025
8-K Current report
Other events
Mar 6, 2025 Mar 3, 2025
10-Q Quarterly report Feb 13, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 13, 2025 Feb 13, 2025
8-K Current report
Other events
Feb 5, 2025 Feb 5, 2025
8-K Current report
Other events
Jan 14, 2025 Jan 14, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 10, 2025
8-K Current report
Regulation FD disclosure
Dec 6, 2024 Dec 6, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
8-K Current report
Shareholder vote results
Aug 28, 2024 Aug 26, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
DEFA14A Additional proxy material Jul 17, 2024 —
DEF 14A Proxy statement Jul 17, 2024 Aug 26, 2024
8-K Current report
Auditor change
Jul 12, 2024 Jul 8, 2024
8-K Current report
Other events
Jul 10, 2024 Jul 9, 2024
8-K Current report
Other events
Jun 28, 2024 Jun 27, 2024
S-8 Employee stock plan registration Jun 17, 2024 —
8-K Current report
Results of operations
Jun 11, 2024 Jun 11, 2024
10-K Annual report Jun 11, 2024 Mar 31, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 29, 2024
8-K Current report
Other events
May 24, 2024 May 23, 2024
8-K Current report
Other events
Apr 26, 2024 Apr 25, 2024
DEF 14A Proxy statement Apr 16, 2024 May 29, 2024
PRE 14A Preliminary proxy statement Apr 5, 2024 May 29, 2024
8-K Current report
Other events
Apr 1, 2024 Apr 1, 2024
EFFECT Filing Feb 29, 2024 —
CORRESP Letter to the SEC Feb 27, 2024 —
UPLOAD Letter from the SEC Feb 16, 2024 —
S-3 Shelf registration Feb 13, 2024 —
8-K Current report
Results of operations
Feb 13, 2024 Feb 13, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 8, 2024
8-K Current report
Other events
Jan 3, 2024 Dec 27, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K/A Amended current report
Other events
Nov 7, 2023 Nov 2, 2023
8-K Current report
Other events
Nov 6, 2023 Nov 2, 2023
8-K Current report
Officer or director change
Oct 26, 2023 Oct 24, 2023
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 4, 2023 Oct 2, 2023
424B5 Prospectus supplement Oct 3, 2023 —
8-K Current report
Other events
Oct 2, 2023 Oct 2, 2023
8-K Current report
Shareholder vote results
Sep 29, 2023 Sep 25, 2023
8-K Current report
Other events
Sep 13, 2023 Sep 12, 2023
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Sep 8, 2023 Sep 1, 2023
8-K Current report
Officer or director change
Aug 22, 2023 Aug 21, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
424B5 Prospectus supplement Aug 8, 2023 —
8-K Current report
Regulation FD disclosure
Aug 7, 2023 Aug 7, 2023
DEFA14A Additional proxy material Jul 28, 2023 —
DEF 14A Proxy statement Jul 28, 2023 Sep 25, 2023
8-K Current report
Other events
Jul 18, 2023 Jul 17, 2023
8-K Current report
Other events
Jul 13, 2023 Jul 13, 2023
8-K Current report
Officer or director change
Jul 7, 2023 Jul 7, 2023
424B5 Prospectus supplement Jun 30, 2023 —
10-K Annual report Jun 28, 2023 Mar 31, 2023
8-K Current report
Results of operations
Jun 28, 2023 Jun 28, 2023
8-K Current report
Other events
Jun 23, 2023 Jun 22, 2023
8-K Current report
Other events
Jun 21, 2023 Jun 21, 2023
8-K Current report
Other events
Jun 13, 2023 Jun 13, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 7, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jun 6, 2023 Jun 6, 2023
8-K Current report
Other events
Jun 1, 2023 Jun 1, 2023
8-K Current report
Regulation FD disclosure
Apr 27, 2023 Apr 27, 2023
8-K Current report
Other events
Apr 19, 2023 Apr 19, 2023
8-K Current report
Other events
Apr 6, 2023 Apr 6, 2023
8-K Current report
Other events
Mar 30, 2023 Mar 30, 2023
8-K Current report
Other events
Mar 23, 2023 Mar 22, 2023
EFFECT Filing Mar 21, 2023 —
CORRESP Letter to the SEC Mar 17, 2023 —
S-3/A Form s-3/a Mar 17, 2023 —
UPLOAD Letter from the SEC Mar 9, 2023 —
8-K Current report
Other events
Mar 8, 2023 Mar 8, 2023
8-K Current report
Listing notice
Mar 7, 2023 Mar 7, 2023
S-3 Shelf registration Mar 2, 2023 —
8-K Current report
Other events
Mar 2, 2023 Mar 1, 2023
D Filing Feb 21, 2023 —
8-K Current report
Results of operations
Feb 7, 2023 Feb 7, 2023
10-Q Quarterly report Feb 7, 2023 Dec 31, 2022
8-K Current report
Unregistered share sale, Other events
Feb 2, 2023 Feb 2, 2023
8-K Current report
Other events
Jan 25, 2023 Jan 24, 2023
8-K Current report
Other events
Jan 12, 2023 Jan 10, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Dec 21, 2022 Dec 20, 2022
8-K Current report
Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Other events
Dec 1, 2022 Nov 30, 2022
8-K Current report
Regulation FD disclosure
Nov 23, 2022 Nov 22, 2022
8-K Current report
Officer or director change, Other events
Nov 22, 2022 Nov 16, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Shareholder vote results
Oct 28, 2022 Oct 28, 2022
8-K Current report
Shareholder vote results, Regulation FD disclosure
Oct 19, 2022 Oct 14, 2022
DEFA14A Additional proxy material Oct 6, 2022 —
8-K Current report
Other events
Oct 6, 2022 Oct 6, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2022 Sep 8, 2022
8-K Current report
Listing notice
Sep 7, 2022 Sep 6, 2022
DEFA14A Additional proxy material Aug 31, 2022 —
DEF 14A Proxy statement Aug 31, 2022 Oct 14, 2022
8-K Current report
Bylaw or fiscal year change
Aug 31, 2022 Aug 30, 2022
PRE 14A Preliminary proxy statement Aug 22, 2022 Oct 14, 2022
8-K Current report
Regulation FD disclosure
Aug 17, 2022 Aug 11, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Other events
Jul 22, 2022 Jul 22, 2022
8-K Current report
Results of operations
Jun 23, 2022 Jun 23, 2022
10-K Annual report Jun 23, 2022 Mar 31, 2022
8-K Current report
Officer or director change, Other events
Jun 22, 2022 Jun 15, 2022
8-K Current report
Regulation FD disclosure
Jun 9, 2022 Jun 8, 2022
8-K Current report
Other events
May 6, 2022 May 5, 2022
8-K Current report
Officer or director change
May 3, 2022 May 2, 2022
8-K Current report
Other events
Apr 22, 2022 Apr 21, 2022
8-K Current report
Other events
Apr 13, 2022 Apr 12, 2022
8-K Current report
Results of operations
Feb 10, 2022 Feb 10, 2022
10-Q Quarterly report Feb 10, 2022 Dec 31, 2021
CT ORDER Filing Nov 16, 2021 —
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Other events
Oct 15, 2021 Oct 14, 2021
8-K Current report
Other events
Oct 5, 2021 Oct 5, 2021
S-8 Employee stock plan registration Sep 24, 2021 —
8-K Current report
Shareholder vote results
Sep 17, 2021 Sep 17, 2021
8-K Current report
Other events
Sep 13, 2021 Sep 13, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
DEFA14A Additional proxy material Jul 29, 2021 —
DEF 14A Proxy statement Jul 29, 2021 Sep 17, 2021
8-K Current report
Officer or director change
Jul 22, 2021 Jul 21, 2021
8-K Current report
Auditor change
Jul 21, 2021 Jul 15, 2021
8-K Current report
Officer or director change
Jul 8, 2021 Jul 6, 2021
8-K Current report
Results of operations
Jun 29, 2021 Jun 29, 2021
10-K Annual report Jun 29, 2021 Mar 31, 2021
8-K Current report
Other events
Jun 17, 2021 Jun 16, 2021
8-K Current report
Regulation FD disclosure
Jun 15, 2021 Jun 14, 2021
8-K Current report
Other events
May 27, 2021 May 26, 2021
8-K Current report
Material agreement
May 14, 2021 May 14, 2021
424B5 Prospectus supplement May 14, 2021 —
8-K Current report
Officer or director change
May 4, 2021 May 1, 2021
8-K Current report
Officer or director change
Apr 27, 2021 Apr 23, 2021
8-K Current report
Other events
Apr 26, 2021 Apr 26, 2021
EFFECT Filing Mar 26, 2021 —
CORRESP Letter to the SEC Mar 23, 2021 —
UPLOAD Letter from the SEC Mar 22, 2021 —
S-3 Shelf registration Mar 15, 2021 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Mar 5, 2021 Mar 5, 2021
8-K Current report
Results of operations
Feb 12, 2021 Feb 11, 2021
10-Q Quarterly report Feb 11, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Feb 2, 2021 Feb 1, 2021
DEF 14A Proxy statement Jan 14, 2021 Jan 14, 2021
8-K Current report
Other events
Jan 6, 2021 Jan 5, 2021
PRE 14A Preliminary proxy statement Dec 31, 2020 Dec 31, 2020
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Dec 22, 2020 Dec 18, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VTGN (Nasdaq)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1411685
Former names
Excaliber Enterprises, Ltd. (until Jun 8, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.